Fig. 1From: Impact of dead time on quantitative 177Lu-SPECT (QSPECT) and kidney dosimetry during PRRTDead time and renal dosimetry in personalized PRRT. The dead-time count loss affecting day 1 (a) and day 3 (b) QSPECT scans, the renal absorbed dose (c) and its deviation without dead-time correction (d) are plotted against the injected activityBack to article page